Loading…
CorMedix Inc. is projected to rise to $12.87 by 2027, a +52% move from its current price of $8.46. CRMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $8.27 | $8.47 | $8.66 | +0.06% |
| May 30 | $8.20 | $8.47 | $8.75 | +0.13% |
| May 31 | $8.15 | $8.48 | $8.82 | +0.19% |
| Jun 1 | $8.10 | $8.48 | $8.88 | +0.25% |
| Jun 2 | $8.07 | $8.49 | $8.93 | +0.32% |
| Jun 3 | $8.03 | $8.49 | $8.98 | +0.38% |
| Jun 4 | $8.00 | $8.50 | $9.03 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.00 | $8.50 | $9.03 | +0.45% |
| Week 2 | $7.84 | $8.54 | $9.29 | +0.89% |
| Week 3 | $7.72 | $8.57 | $9.52 | +1.34% |
| Week 4 | $7.64 | $8.61 | $9.71 | +1.80% |
| Week 5 | $7.56 | $8.65 | $9.90 | +2.25% |
| Week 6 | $7.50 | $8.69 | $10.07 | +2.71% |
| Week 7 | $7.44 | $8.73 | $10.23 | +3.16% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
The company is categorized in Healthcare and was formerly known as Picton Holding Company, Inc., changing its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
CorMedix Inc. trades at $7.98 per share and has a market capitalization of $626.05M, with a rank of 2868. The current price sits within a forecasted trajectory that shows meaningful potential in the coming years.
Forecast data indicate the average price rises through 2026–2050, with projected averages from $7.98 in 2026 to $102.06 in 2050, and max values reaching as high as $176.85 by 2050. The outlook shifts from neutral in 2026 to bullish in subsequent years, with an ROI advancing from 0% in 2026 to 1179% by 2050.
A major floor 26.1% below — a decisive break under it would weaken the trend.
The nearest floor, 15.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 10.5% above — clearing it would confirm fresh momentum.
Key CRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.14 | Buy | $8.18 | Buy |
| MA 10 | $7.94 | Buy | $8.03 | Buy |
| MA 20 | $7.85 | Buy | $7.86 | Buy |
| MA 50 | $7.35 | Buy | $7.64 | Buy |
| MA 100 | $7.47 | Buy | $7.99 | Buy |
| MA 200 | $9.54 | Sell | $8.77 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.92 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 203.80 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 6.82 | Buy |
| Bollinger %B (20,2) | 1.11 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 0.48 | Buy |
| Ultimate (7,14,28) | 74.85 | Sell |
| Momentum (10) | 0.95 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 8.31 | Buy |
| ADX (14) | 16.79 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 60. The asset trades above the SMA50 of $7.28 but below the SMA200 at $9.56, suggesting near-term momentum inconsistencies. Support is indicated at $7.13 and resistance at $8.06, with a 30-day range of $6.87 to $9.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.25 | $8.46 | $12.38 | 0% | Neutral | |
| $10.37 | $12.87 | $16.81 | +52% | Bullish | |
| $11.27 | $14.30 | $19.25 | +69% | Bullish | |
| $13.00 | $16.80 | $23.18 | +99% | Bullish | |
| $14.62 | $19.20 | $27.05 | +127% | Bullish | |
| $15.09 | $20.12 | $28.86 | +138% | Bullish | |
| $19.19 | $25.94 | $37.81 | +207% | Bullish | |
| $23.53 | $32.22 | $47.67 | +281% | Bullish | |
| $24.97 | $34.62 | $51.93 | +309% | Bullish | |
| $27.31 | $38.31 | $58.21 | +353% | Bullish | |
| $44.93 | $66.44 | $106.51 | +685% | Bullish | |
| $77.16 | $124.77 | $216.49 | +13.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.25 | $8.46 | $9.97 | +0.00% |
| June 2026 | $7.58 | $8.87 | $10.61 | +4.89% |
| July 2026 | $7.61 | $8.97 | $10.84 | +1.03% |
| August 2026 | $7.72 | $9.15 | $11.16 | +2.08% |
| September 2026 | $8.06 | $9.59 | $11.78 | +4.83% |
| October 2026 | $8.20 | $9.80 | $12.12 | +2.19% |
| November 2026 | $8.11 | $9.73 | $12.09 | -0.74% |
| December 2026 | $8.23 | $9.91 | $12.38 | +1.81% |
Click any year to see its month-by-month CRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CRMD is projected to trade between $6.25 and $12.38, averaging $8.46 — a potential gain of 0% from today's $8.46. A consolidation phase looks the most probable path here.
CorMedix Inc.'s 2027 outlook centres on $12.87, within a $10.37 to $16.81 range. That is up +52% on the projected 2026 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2028, CRMD could reach as high as $19.25, with a base case around $14.30 and support toward $11.27 — roughly +69% from $8.46. Buyers look set to stay in control over this stretch.
Expect CRMD to range from $13.00 to $23.18 through 2029. The $16.80 average target implies a +99% move from current prices. That is up +18% on the projected 2028 average. Momentum favours further upside here.
The CRMD price prediction for 2030 points to an average of $19.20 (low $14.62, high $27.05) — a potential gain of +127% on today's $8.46. Buyers look set to stay in control over this stretch.
In 2031, CRMD is projected to trade between $15.09 and $28.86, averaging $20.12 — a potential gain of +138% from today's $8.46. That is up +5% on the projected 2030 average. Momentum favours further upside here.
CorMedix Inc.'s 2032 outlook centres on $25.94, within a $19.19 to $37.81 range. That is up +29% on the projected 2031 average. That marks a +207% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CRMD could reach as high as $47.67, with a base case around $32.22 and support toward $23.53 — roughly +281% from $8.46. Momentum favours further upside here.
Expect CRMD to range from $24.97 to $51.93 through 2034. The $34.62 average target implies a +309% move from current prices. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CRMD price prediction for 2035 points to an average of $38.31 (low $27.31, high $58.21) — a potential gain of +353% on today's $8.46. Momentum favours further upside here.
In 2040, CRMD is projected to trade between $44.93 and $106.51, averaging $66.44 — a potential gain of +685% from today's $8.46. That is up +73% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CorMedix Inc.'s 2050 outlook centres on $124.77, within a $77.16 to $216.49 range. That is up +88% on the projected 2040 average. That marks a +13.7x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CRMD today (≈ 118.20331 CRMD) could be worth
$14,748.53
+$13,748.53 (+1375%) by 2050 · US Dollar
Based on the average projected CRMD price of $124.77 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRMDwould be worth at today's price.
$1,000 invested in CRMD on May 27, 2025 (≈ 79.808461 CRMD) would be worth
$675.18
-$324.82 (-32.5%) today · 0.68× · US Dollar
Based on a CRMD entry price of $12.53 vs. today's $8.46.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.93 | $1,066.83 | +6.7% |
| 1 month ago | $7.82 | $1,081.84 | +8.2% |
| 3 months ago | $7.35 | $1,151.02 | +15.1% |
| 6 months ago | $9.81 | $862.39 | -13.8% |
| 1 year ago | $12.53 | $675.18 | -32.5% |
| All time (5.0y) ago | $7.31 | $1,157.32 | +15.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRMD forecast.
Our base-case forecast reaches $17.00 around 2030.
Implied market cap at $17.00: $1.33B
The multi-year forecast points to a bullish trajectory with higher averages and sizable ROI growth. By 2030, the average price is projected at $17.12 with a 114.5% ROI. The 2040 forecast raises the average to $55.38 and a 594% ROI, while 2050 projects an average of $102.06 with a 1179% ROI.
These figures imply a meaningful ascent from current levels, though they remain estimates subject to market risk. The sentiment is listed as BULLISH across the longer horizon. The path underscores higher potential prices over time, paired with increasingly large projected returns, but it is not a guarantee and depends on future market dynamics.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $17.12 with a maximum of $24.10 and a minimum of $13.04, and a projected ROI of 114.5%. The sentiment is BULLISH.
Forecasts show a bullish trend from 2027 onward, with the average price rising from $11.91 in 2027 to $17.12 in 2030 and beyond, and ROI increasing to 114.5% by 2030, 594% by 2040, and 1179% by 2050.
Yes. The 2050 forecast lists an average price of $102.06 and a maximum of $176.85, indicating potential to surpass $100 in the longer term.
The current price is $7.98 and the market capitalization is $626.05M.
The 30-day range is $6.87 to $9.27, with support at $7.13 and resistance at $8.06. The RSI(14) is 60, and the SMA50 is $7.28 while the SMA200 is $9.56, indicating mixed near-term momentum.
CorMedix Inc. Community Discussion
0Share your CorMedix Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.